GlassScriptPhysician profile
Keith T Kawamura
NPI 1790792760
$7,387.40
in general payments reported to CMS, 2019-2025
17 companies · $1,241 in 2025
The $1,241 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $444 · 2020: $137 · 2021: $695 · 2022: $1,452 · 2023: $2,983 · 2024: $436 · 2025: $1,241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,496 · Travel and Lodging: $2,146 · Entertainment: $18.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,495.91 |
| Travel and Lodging | $2,146.19 |
| Entertainment | $18.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $2,771.07 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $1,321.61 | 2022-2025 | Infuse, Biotrue One Day, Infuse Multifocal |
| Coopervision INC. | $1,108.65 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Alcon Vision LLC | $325.36 | 2019-2022 | |
| Abbvie INC. | $324.93 | 2022-2023 | |
| Tarsus Pharmaceuticals, INC. | $276.37 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $224.29 | 2019-2021 | |
| Genentech USA, INC. | $149.65 | 2022 | |
| Horizon Therapeutics Plc | $138.22 | 2023 | Tepezza |
| Lkc Technologies, INC. | $133.98 | 2025 | |
| Ivantis, INC | $126.28 | 2021 | |
| Kala Pharmaceuticals, INC. | $119.41 | 2021 | |
| Novartis Pharmaceuticals Corporation | $112.47 | 2020 | |
| Glaukos Corporation | $102.43 | 2021 | |
| Allergan, INC. | $81.55 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $46.93 | 2022-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Johnson & Johnson Surgical Vision, INC. | $24.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Kawamura listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.